Last edition
News about " GlaxoSmithKline (GSK) "
GSK Q2 Sales Hit GBP 8 Billion, Driven Mainly by Specialty Medicines
GSK has delivered robust second-quarter 2025 results, fueled primarily by strong growth in its Specialty Medicines portfolio.
GlaxoSmithKline (GSK) | 31/07/2025 | By Dineshwori | 104
FDA to Review GSK's Application to Expand Arexvy RSV Vaccine Use
The US Food and Drug Administration (FDA) has accepted to review GlaxoSmithKline (GSK)'s application to expand the use of its RSV vaccine, Arexvy, to include adults aged 18–49 who are at increased risk.
GlaxoSmithKline (GSK) | 16/07/2025 | By Dineshwori | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy